Charges: 2 Minnesota men cheated buyers out of $46M by selling grains falsely labeled as organic

The scheme ran from 2014 to 2021, according to prosecutors.

January 17, 2023 at 4:59PM
Wheat grows in a field in Tribune, Kan. (Michael Ciaglo, Bloomberg/The Minnesota Star Tribune)

A second Minnesota man has been charged with being part of a plot to defraud grain purchasers out of more than $46 million by selling grains falsely labeled as organic.

Cottonwood County farmers James C. Wolf, 65, and Adam C. Olson, 45, are both charged in U.S. District Court in Minneapolis with three counts of wire fraud and one count of conspiracy in connection with the scheme that ran from 2014 to 2021, the U.S. Attorney's Office announced Friday.

Wolf was charged in July and has made his initial court appearance, while Olson's first hearing is scheduled for Jan. 23. Messages were left Tuesday with both men and their attorneys seeking a response to the allegations.

According to the charges:

From 2014 to 2021, Wolf repeatedly purchased non-organic corn and soybeans from a grain seller and resold them as organic. He made the transactions despite not having the required grain buyer license.

He also grew conventionally farmed crops using chemical fertilizers and pesticides, in violation of organic farming standards, and provided grain purchasers with copies of his National Organics Program certification but withheld that the grains were not organically farmed.

After Wolf's organic farming certification was revoked in 2020, Olson, who was certified, helped Wolf sell non-GMO crops falsely described as organic.

"As a result of the fraud scheme, Wolf and Olson received more than $46 million in payments from grain buyers," the charges read.

about the writer

about the writer

Paul Walsh

Reporter

Paul Walsh is a general assignment reporter at the Star Tribune. He wants your news tips, especially in and near Minnesota.

See More

More from Business

card image

With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the fast-growing sector for “pulsed field” atrial fibrillation treatments.